Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland - PubMed (original) (raw)

Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland

O Lesouhaitier et al. J Mol Endocrinol. 1998 Feb.

Abstract

Diazepam-binding inhibitor (DBI) was initially isolated from the rat brain as a result of its ability to compete with benzodiazepines for their receptors. Immunohistochemical studies have recently shown the presence of peripheral-type benzodiazepine receptor (PBR)- and DBI-like immunoreactivity in the frog adrenal gland. The aim of the present study was to investigate the effect of two biologically active DBI-derived peptides, the triakontatetraneuropeptide [TTN; DBI(17-50)] and the octadecaneuropeptide [ODN; DBI(33-50)], on corticosteroid secretion by frog adrenocortical cells. Exposure of frog adrenal explants to graded concentrations of TTN (3.16 x 10(-8) to 3.16 x 10(-6) M) induced a dose-related increase in corticosterone and aldosterone secretion. In contrast, ODN did not modify corticosteroid output. When repeated pulses of TTN (10(-6) M) were administered at 2-h intervals, the response of the adrenal explants to the second dose of TTN was markedly reduced, suggesting the existence of a desensitization phenomenon. Exposure of dispersed adrenal cells to TTN also induced a marked stimulation of corticosteroid secretion, indicating that TTN acts directly on adrenocortical cells. The central-type benzodiazepine receptor (CBR) agonist, clonazepam, did not stimulate corticosteroid secretion and the CBR antagonist, flumazenil, did not block the stimulatory action of TTN. Similarly, the PBR agonist, Ro5-4864, did not mimic the stimulatory effect of TTN and the PBR antagonist, flunitrazepam, did not affect the stimulatory action of TTN. The present study provides the first evidence for a stimulatory effect of TTN on intact adrenocortical cells. The receptor mediating the corticotropic action of TTN is not related to central- or peripheral-type benzodiazepine receptors. Our data suggest that TTN, released by chromaffin cells, may act as a paracrine factor regulating the activity of adrenocortical cells.

PubMed Disclaimer

Cited by

Macroglia-microglia interactions via TSPO signaling regulates microglial activation in the mouse retina.
Wang M, Wang X, Zhao L, Ma W, Rodriguez IR, Fariss RN, Wong WT. Wang M, et al. J Neurosci. 2014 Mar 5;34(10):3793-806. doi: 10.1523/JNEUROSCI.3153-13.2014. J Neurosci. 2014. PMID: 24599476 Free PMC article.
Regulation of neurosteroid biosynthesis by neurotransmitters and neuropeptides.
Do Rego JL, Seong JY, Burel D, Leprince J, Vaudry D, Luu-The V, Tonon MC, Tsutsui K, Pelletier G, Vaudry H. Do Rego JL, et al. Front Endocrinol (Lausanne). 2012 Jan 24;3:4. doi: 10.3389/fendo.2012.00004. eCollection 2012. Front Endocrinol (Lausanne). 2012. PMID: 22654849 Free PMC article.
The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.
do Rego JL, Vaudry D, Vaudry H. do Rego JL, et al. PLoS One. 2015 Mar 18;10(3):e0120473. doi: 10.1371/journal.pone.0120473. eCollection 2015. PLoS One. 2015. PMID: 25785994 Free PMC article.

Effect of the triakontatetraneuropeptide (TTN) on corticosteroid secretion by the frog adrenal gland - PubMed (original) (raw)